Literature DB >> 12990672

Bacteriology of the human liver.

V M SBOROV, W C MORSE, B GIGES, E J JAHNKE.   

Abstract

Entities:  

Keywords:  LIVER

Mesh:

Year:  1952        PMID: 12990672      PMCID: PMC436501          DOI: 10.1172/JCI102692

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Bacteriologic study of the human liver.

Authors:  C ROMIEU; A BRUNSCHWIG
Journal:  Surgery       Date:  1951-10       Impact factor: 3.982

2.  Effects of the ligation of the hepatic artery in dogs.

Authors:  D FRASER; A M RAPPAPORT; C A VUYLSTEKE; A R COLWELL
Journal:  Surgery       Date:  1951-10       Impact factor: 3.982

3.  The effect of aureomycin on the radiation syndrome in dogs.

Authors:  F W FURTH; M P COULTER; J W HOWLAND
Journal:  Am J Pathol       Date:  1952 Jan-Feb       Impact factor: 4.307

4.  Clostridial infection as a cause of death after ligation of the hepatic artery.

Authors:  A Y S CHAU; V C GOLDBLOOM; F N GURD
Journal:  AMA Arch Surg       Date:  1951-09

5.  Ligation of the hepatic and splenic arteries in the treatment of portal hypertension with a report of six cases; preliminary report.

Authors:  W F REINHOFF
Journal:  Bull Johns Hopkins Hosp       Date:  1951-04

6.  Studies on the use of aureomycin in hepatic disease. II. The effect of aureomycin on experimental dietary hepatic necrosis.

Authors:  P GYORGY; J STOKES; W H SMITH; H GOLDBLATT
Journal:  Am J Med Sci       Date:  1950-07       Impact factor: 2.378

7.  B. coli septicemia in Laennec's cirrhosis of the liver.

Authors:  R L WHIPPLE; J F HARRIS
Journal:  Ann Intern Med       Date:  1950-08       Impact factor: 25.391

8.  Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma.

Authors:  J D FARQUHAR; J STOKES; C M WHITLOCK; L W BLUEMLE; J M GAMBESCIA
Journal:  Am J Med Sci       Date:  1950-08       Impact factor: 2.378

9.  Studies on the use of aureomycin in hepatic disease. IV. Aureomycin therapy in chronic liver disease; with a note on dermal sensitivity.

Authors:  J M SHAFFER; L W BLUEMLE; V M SBOROV; J R NEEFE
Journal:  Am J Med Sci       Date:  1950-08       Impact factor: 2.378

10.  Antimicrobial agents in the prevention of dietary hepatic injury (necrosis, cirrhosis) in rats.

Authors:  P GYORGY; J STOKES; H GOLDBLATT; H POPPER
Journal:  J Exp Med       Date:  1951-06       Impact factor: 14.307

View more
  7 in total

1.  Experimental hepatic ischemia; collateral circulation of the liver.

Authors:  A M RAPPAPORT; W N LOTTO; W M LOUGHEED
Journal:  Ann Surg       Date:  1954-11       Impact factor: 12.969

2.  Bacteriologic studies of biliary tract infection.

Authors:  R J Flemma; L M Flint; S Osterhout; W W Shingleton
Journal:  Ann Surg       Date:  1967-10       Impact factor: 12.969

3.  Are hepatic arteries end-arteries?

Authors:  E T Mays; E T Mays
Journal:  J Anat       Date:  1983-12       Impact factor: 2.610

4.  [Experimental gallstone formation. Etiological significance of beta-glucuronidase producing bacteria and biliary obstruction].

Authors:  E Hancke; G Marklein
Journal:  Langenbecks Arch Chir       Date:  1983

5.  A bacteriologic study of human portal blood: implications regarding hepatic ischemia in man.

Authors:  M J ORLOFF; G W PESKIN; H L ELLIS
Journal:  Ann Surg       Date:  1958-11       Impact factor: 12.969

6.  Bacteremia: a consideration of some experimental and clinical aspects.

Authors:  I L BENNETT; P B BEESON
Journal:  Yale J Biol Med       Date:  1954-02

7.  The relationship between bacterial infection of the hepato-biliary system and common bile duct obstruction in man.

Authors:  L R FREEDMAN; I S GOLDENBERG
Journal:  Yale J Biol Med       Date:  1963-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.